These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 7661587)

  • 1. Usefulness of the Thai modified functional living index--cancer (T-FLIC) and the Thai modified quality of life index (T-QLI) for advanced non-small cell lung cancer.
    Thongprasert S; Sanquanmitr P
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():226-9. PubMed ID: 7661587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in pretreatment quality of life in a prospective lung cancer trial.
    Siddiqui F; Kohl R; Swann S; Watkins-Bruner D; Movsas B
    J Support Oncol; 2008 Jan; 6(1):33-9. PubMed ID: 18257399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy.
    Thongprasert S; Sanguanmitra P; Juthapan W; Clinch J
    Lung Cancer; 1999 Apr; 24(1):17-24. PubMed ID: 10403690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.
    de Boer RH; Smith IE; Pastorino U; O'Brien ME; Ramage F; Ashley S; Goldstraw P
    Br J Cancer; 1999 Mar; 79(9-10):1514-8. PubMed ID: 10188899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of the Thai-modified Function Living Index Cancer questionnaire version 2 (T-FLIC 2) for the evaluation of quality of life in non-small cell lung cancer patients.
    Thongprasert S; Intarapak S; Saengsawang P; Thaikla K
    J Med Assoc Thai; 2005 Dec; 88(12):1809-15. PubMed ID: 16518978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life.
    Spiro SG; Rudd RM; Souhami RL; Brown J; Fairlamb DJ; Gower NH; Maslove L; Milroy R; Napp V; Parmar MK; Peake MD; Stephens RJ; Thorpe H; Waller DA; West P;
    Thorax; 2004 Oct; 59(10):828-36. PubMed ID: 15454647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer.
    Müller H
    Eur J Surg Oncol; 2002 Mar; 28(2):165-71. PubMed ID: 11884052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
    J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
    Yano T; Koga T; Nomiyama H; Hidaka H
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):959-62. PubMed ID: 12894710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
    O'Brien ME; Saini A; Smith IE; Webb A; Gregory K; Mendes R; Ryan C; Priest K; Bromelow KV; Palmer RD; Tuckwell N; Kennard DA; Souberbielle BE
    Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of the quality of life of cancer patients. The preliminary applications to advanced bronchial cancers].
    Belpomme D; Le Rol A; Pappo F; Bernheim J; Dautzenberg B; Brechot JM; Chastang C; Guerin RA
    Bull Cancer; 1986; 73(5):627-33. PubMed ID: 3022852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer.
    Ganz PA; Haskell CM; Figlin RA; La Soto N; Siau J
    Cancer; 1988 Feb; 61(4):849-56. PubMed ID: 3276389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychological evaluation in chemotherapy of lung cancer].
    Konishi M; Mikasa K; Fukuoka K; Maeda K; Sasaki Y; Tomoda K; Konoike Y; Sawaki M; Narita N
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1407-9. PubMed ID: 1503492
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study.
    Finkelstein DM; Cassileth BR; Bonomi PD; Ruckdeschel JC; Ezdinli EZ; Wolter JM
    Am J Clin Oncol; 1988 Dec; 11(6):630-3. PubMed ID: 3055933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of performance status 2 patients with advanced non-small-cell lung cancer: what we know and what we don't know.
    Tartarone A; Aieta M
    Future Oncol; 2009 Aug; 5(6):837-41. PubMed ID: 19663733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.